Most AML conditions with IDH1/2 mutation are grouped morphologically as AML having or not having myeloid maturation, which is represented as FAB (French–American–British) classification M1 or M2, respectively [9]. The gene discussed is IDH1; the disease is acute myeloid leukemia.